Wed, July 8, 2020

Matthew Harrison Downgraded (BMRN) to Hold and Held Target at $125 on, Jul 8th, 2020

Matthew Harrison of Morgan Stanley, Downgraded "BioMarin Pharmaceutical Inc." (BMRN) to Hold and Held Target at $125 on, Jul 8th, 2020.

Matthew, nor any peers, have made any analyst calls on BMRN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30